Eton Pharmaceuticals Inc (NASDAQ: ETON) kicked off on Tuesday, up 9.80% from the previous trading day, before settling in for the closing price of $14.39. Over the past 52 weeks, ETON has traded in a range of $3.25-$21.48.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 32.22% over the last five years. While this was happening, its average annual earnings per share was recorded 402.22%. With a float of $22.95 million, this company’s outstanding shares have now reached $26.82 million.
The firm has a total of 31 workers. Let’s measure their productivity. In terms of profitability, gross margin is 58.49%, operating margin of -4.69%, and the pretax margin is -9.3%.
Eton Pharmaceuticals Inc (ETON) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Eton Pharmaceuticals Inc is 14.41%, while institutional ownership is 52.89%. The most recent insider transaction that took place on Jun 12 ’25, was worth 253,297. In this transaction Chief Business Officer of this company sold 16,977 shares at a rate of $14.92, taking the stock ownership to the 629,669 shares. Before that another transaction happened on Jun 16 ’25, when Company’s Chief Business Officer sold 10,223 for $14.73, making the entire transaction worth $150,585. This insider now owns 612,646 shares in total.
Eton Pharmaceuticals Inc (ETON) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 402.22% per share during the next fiscal year.
Eton Pharmaceuticals Inc (NASDAQ: ETON) Trading Performance Indicators
Take a look at Eton Pharmaceuticals Inc’s (ETON) current performance indicators. Last quarter, stock had a quick ratio of 1.43. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.77. Likewise, its price to free cash flow for the trailing twelve months is 76.76.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.18, a number that is poised to hit 0.01 in the next quarter and is forecasted to reach 1.28 in one year’s time.
Technical Analysis of Eton Pharmaceuticals Inc (ETON)
Analysing the last 5-days average volume posted by the [Eton Pharmaceuticals Inc, ETON], we can find that recorded value of 0.49 million was better than the volume posted last year of 0.36 million. As of the previous 9 days, the stock’s Stochastic %D was 87.14%.
During the past 100 days, Eton Pharmaceuticals Inc’s (ETON) raw stochastic average was set at 45.35%, which indicates a significant decrease from 96.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.83 in the past 14 days, which was lower than the 1.02 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $16.51, while its 200-day Moving Average is $13.30. Now, the first resistance to watch is $16.32. This is followed by the second major resistance level at $16.83. The third major resistance level sits at $17.75. If the price goes on to break the first support level at $14.88, it is likely to go to the next support level at $13.96. Should the price break the second support level, the third support level stands at $13.45.
Eton Pharmaceuticals Inc (NASDAQ: ETON) Key Stats
The company with the Market Capitalisation of 423.72 million has total of 26,818K Shares Outstanding. Its annual sales at the moment are 39,010 K in contrast with the sum of -3,820 K annual income. Company’s last quarter sales were recorded 17,280 K and last quarter income was -1,570 K.
